Results

Most recent

AMD-Neovascular

1–10 of 63 results for AMD-Neovascular

Outcomes of Anti-VEGF Treatment for CNV in Fellow Eyes of Previously Treated Patients with Wet AMD
Tarek S. Hassan, MD
Updates from the Field
2019
Defining and Addressing Wet AMD Non-responders
Rishi P. Singh, MD
Updates from the Field
2019
Predictors of Post-injection Endophthalmitis: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength
Tarek S. Hassan, MD
Updates from the Field
2019
The Functional Impact of Fluctuating Retinal Thickness in the IVAN and CATT Trials: A Meta-Analysis
Usha Chakravarthy
Updates from the Field
2019
BiWeekly Anti-VEGF Dosing for Chronic Refractory Neovascular Age-Related Macular Degeneration Unresponsive to Standard Monthly Dosing
Eric W Schneider, MD
Updates from the Field
2019
Abicipar Phase 2 MAPLE Trial Supports Improved Safety for Patients with nAMD Following a Modified Manufacturing Process
Raj K. Maturi, MD
Updates from the Field
2019
Differences in Intravitreal Silicone Oil Following Multiple Bevacizumab, Ranibizumab, and Aflibercept Injections
John T. Thompson, MD
Updates from the Field
2019
Interaction of Genotypes and AREDS Formulation Use in the Development of Neovascular AMD
Pradeepa Yoganathan, MD, FRCS(C)
Updates from the Field
2019
Dual Targeting VEGF/Ang3 Surrobody in an Experimental Model of Neovascularization
Jeffrey L. Olson, MD
Annual Meeting Talks
2019
Episode 28: Brolucizumab for wet AMD (HAWK and HARRIER) - Dr. Pravin Dugel
Keyvan Koushan, MD, FRCSC
Member Podcasts